Prion diseases (Transmissible spongiform encephalopathies): A review

Endoscopy

Volumn 29, Issue 6, 1997, Pages 584-592

  Hansen, N J D ^a  

^a GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BOVINE SPONGIFORM ENCEPHALOPATHY; CREUTZFELDT JAKOB DISEASE; DISEASE TRANSMISSION; GASTROINTESTINAL ENDOSCOPY; HEPATITIS C; HUMAN; PRION DISEASE; PRIORITY JOURNAL;

EID: 0030663504     PISSN: 0013726X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1004262     Document Type: Article

References (49)

1. Prusiner SB. Genetic and infectious prion diseases. Arch Neurol 1993; 50: 1129-53.
2. Collinge J. Inherited prion diseases. Adv Neurol 1993; 61: 155-65.
3. Kretzschmar HA. Neuropathology of human prion diseases (spongiform encephalopathies). Dev Biol Stand 1993; 80: 71-90.
4. Kretzschmar HA. Human prion diseases (spongiform encephalopathies). Arch Virol Suppl 1993; 7: 261-93.
5. Prusiner SB, Hsiao KK, Bredesen DE, DeArmond SJ. Prion disease. In: Vinken PJ, Bruyn GW, Klawans HL, editors. Handbook of clinical neurology. Amsterdam: Elsevier, 1989: 543-80.
6. Prusiner SB. Prions. Sci Am 1984 (October): 48-57.
7. Gajdusek DC, Zigas V Clinical, pathological and epidemiological study of an acute progressive degenerative disease of the central nervous system among natives of the eastern highlands of New Guinea. Am J Med 1959; 26: 442-69.
8. Brown P, Gajdusek DC. The human spongiform encephalopathies: kuru, Creutzfeldt-Jakob disease, and the Gerstmann-Sträussler-Scheinker syndrome. Curr Top Microbiol Immunol 1991; 172: 1-20.
9. Gajdusek DC. Subacute spongiform encephalopathies: transmissible cerebral amyloidoses caused by unconventional viruses. In: Fields BN, Knipe DN, Chanock RM et al., editors. Virology. 2nd ed. New York: Raven Press, 1990: 2289-324.
10. Ravilochan K, Tyler KL. Human transmissible neurodegenerative diseases (prion diseases). Semin Neurol 1992; 12: 178-92.
11. Will RG, Ironside JW, Zeidler M, Cousens SN, Estibeiro K, Alperovitch A, et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996; 347: 921-5.
12. Schreuder BEC. Animal spongiform encephalopathy - an update, 1 : scrapie and lesser known animal spongiform encephalopathies. Vet Q 1994; 16: 174-81.
13. British Veterinary Association Bovine spongiform encephalopathy: memorandum of evidence by the British Veterinary Association to the House of Commons Agriculture Committee. Vet Rec 1990; 126: 626-7.
14. Gajdusek DC. Unconventional viruses and the origin and disappearance of kuru. Science 1977; 197: 943-60.
15. Asher DM. Slow injections with unconventional viruses: the subacute spongiform encephalopathies. In: Scheld WM, Whitley RJ, Durack DT, editors. Infections of the central nervous system. New York: Raven Press, 1991: 153-66.
16. Collinge J, Palmer MS. Molecular genetics of prion diseases. Philos Trans R Soc Lond B Biol Sci 1994; 343: 371-8.
17. Prusiner SB. Human prion diseases. In: Zuckerman AJ, Pattison JR, Banatvala JE, eds. Principles and practice of clinical virology. 3 rd ed. Chichester: Wiley, 1994: 703-29.
18. Brown P, Cathala F, Castaigne P, Gajdusek DC. Creutzfeldt-Jakob disease: clinical analysis of a consecutive series of 230 neuropathologically verified cases. Ann Neurol 1986; 20: 597-602.
19. Will RG, Knight RSG, Zeidler K, Stewart G, Ironside JW, Cousens SN, et al. Reporting of suspect new variant Creutz-feldt-Jakob disease. Lancet 1997; 349: 847.
20. Hsiao K, Prusiner SB. Inherited human prion diseases. Neurology 1990; 40: 1820-7.
21. Medori R, Tritschler HJ, LeBlanc A, Villare F, Manetto V, Chen HY, et al. Fatal familial insomnia, a prion disease with a mutation at codon 178 of the prion protein gene. N Engl J Med 1992; 326: 444-9.
22. Prusiner SB. Molecular biology and genetics of prion diseases. Philos Trans R Soc Lond B Biol Sci 1994; 343: 447-63.
23. Liberski PP. The enigma of slow viruses: facts and artefacts. Arch Virol Suppl 19936: 1 -263.
24. Chesebro B. Spongiform encephalopathies: the transmissible agents. In: Fields BN, Knipe DN, Chanock RM, et al. editors. Virology. 2nd ed. New York: Raven Press, 1990: 2325-36.
25. Collinge J, Whittington MA, Sidle KCL, Smith CJ, Palmer MS, Clarke AR, et al. Prion protein is necessary for normal synaptic function. Nature 1994; 370: 295-7.
26. Palmer MS, Collinge J. Human prion diseases. Cur Opin Neurol Neurosurg 1992; 5: 895-901.
27. Dal Canto MC. Human and experimental spongiform encephalopathies: recent progress in pathogenesis. Ital J Neurol Sci 1991; 12: 147-53.
28. Prusiner SB. The prion diseases. Sci Am 1995 (January): 30-7.
29. Prusiner SB, Hsaio KK. Human prion diseases. Ann Neurol 1994; 35: 385-95.
30. Berg LJ. Insights into the role of the immune system in prion diseases. Proc Natl Acad Sci USA 1994; 91: 429-32.
31. Ridley RK, Baker BF. Genetics of human prion disease. In: Brown F, editor. Transmissible spongiform encephalopathies: impact on animal and human health. Dev Biol Stand 1993; 80: 15-23.
32. Brown P, Gibbs CJ Jr, Rodgers-Johnson P, Asher DA, Sulima W, Bacote A, et al. Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol 1994; 35: 513-29.
33. DeArmond SJ. Alzheimer's disease and Creutzfeldt-Jakob disease: overlap of pathogenic mechanisms. Curr Opin Neurol 1993; 6: 872-81.
34. Bradley R. In: Collinge J, Palmer MS, editors. Prion diseases. Oxford: Oxford University Press, 1997: 91-2.
35. Anderson RX, Donnelly CA, Ferguson NK, Woolhouse MEJ, Watt CJ, Udy HJ, et al. Transmission dynamics and epidemiology of BSE in British cattle. Nature 1996; 382: 779-88 [correction in Nature 1997; 386: 302].
36. Collee JG. A dreadful challenge. Lancet 1996; 347: 917-8.
37. Gibson PH. Bovine spongiform encephalopathy. Vet Rec 1990; 126: 608.
38. Wilesmith JW, Wells GAH, Cranwell NW, Ryan JBM. Bovine spongiform encephalopathy: epidemiological studies. Vet Rec 1988; 123: 638-44.
39. Collinge J, Sidle KCL, Meads J, Ironside J, Hill AF. Molecular analysis of prion strain variation and the aetiology of "new variant" CJD. Nature 1996; 383: 685-90.
40. Epstein LG, Brown P. Bovine spongiform encephalopathy and a new variant form of Creutzfeldt-Jakob disease. Neurology 1997:48: 569-71.
41. Advisory Committee on Dangerous Pathogens. Categorisation of biological agents according to hazard and categories of containment. 4th ed.: HSE Books, 1995.
42. Budka H, Aguzzi A, Brown P, Brucher JM, Bugiani O, Collinge J, et al. Consensus report: tissue handling in suspected Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol 1995; 5: 319-22.
43. Morris K. WHO reconsiders risks from Creutzfeldt-Jakob disease. Lancet 1997; 349: 1001.
44. Advisory Committee on Dangerous Pathogens. Precautions for work with human and animal transmissible spongiform encephalopathies. London: HMSO, 1994.
45. Ironside JW, Bell JE. The "high-risk" neuropathological autopsy in AIDS and Creutzfeldt-Jakob disease: principles and practice. Neuropathol Appl Neurobiol 1996; 22: 388-93.
46. Barboriak DP, Provenzale JK Boyko OB. MR diagnosis of Creutzfeldt-Jakob disease: significance of high signal intensity of the basal ganglia. AJR Am J Roentgenol 1994; 162: 137-41.
47. Onofri M, Fulgente T, Gambi D, Macchi G. Early NM findings in Creutzfeldt-Jakob disease. J Neurol 1993; 240: 423-6.
48. Di Rocco A, Molinari S, Stollman AL, Decker A, Yahr MD. NM abnormalities in Creutzfeldt-Jakob disease. Neuroradiology 1993; 35: 584-5.
49. Hill AF, Zeidler M, Ironside J, Collinge J. Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy. Lancet 1997; 349: 99-100.